Meg Jardine's Publications

About Meg Jardine's Publications

Honorary Professorial Fellow, The George Institute for Global Health
  • Associate Professor, Faculty of Medicine, UNSW Sydney

  • Acute interstitial nephritis and nephrogenic diabetes insipidus following treatment with sulfamethoxazole-trimethoprim and temozolomide

    Nephrology Date published:

  • International consensus definitions of clinical trial outcomes for kidney failure: 2020

    Kidney International Date published:

  • Forgotten Technology in the COVID-19 Pandemic: Filtration Properties of Cloth and Cloth Masks-A Narrative Review

    Mayo Clinic Proceedings Date published:

  • Early Change in Albuminuria with Canagliflozin Predicts Kidney and Cardiovascular Outcomes: A Post Hoc Analysis from the CREDENCE Trial

    Journal of the American Society of Nephrology Date published:

  • Haemodialysis duration, frequency and intensity for end-stage kidney disease

    Cochrane Database of Systematic Reviews Date published:

  • Cloth Masks May Prevent Transmission of COVID-19: An Evidence-Based, Risk-Based Approach

    Annals of Internal Medicine Date published:

  • Therapy Escalation Following an Elevated HbA1c in Adults Aged 45 Years and Older Living With Diabetes in Australia: A Real-World Observational Analysis

    Diabetes Care Date published:

  • A Randomized Trial on the Effect of Phosphate Reduction on Vascular End Points in CKD (IMPROVE-CKD)

    Journal of the American Society of Nephrology Date published:

  • Kidney and cardiovascular protection with SGLT2 inhibitors: lessons from cardiovascular outcome trials and CREDENCE

    Journal of Nephrology Date published:

  • Comparative Efficacy and Safety of BP-Lowering Pharmacotherapy in Patients Undergoing Maintenance Dialysis

    Clinical Journal of the American Society of Nephrology Date published:

  • No evidence of a legacy effect on survival following randomization to extended hours dialysis in the ACTIVE Dialysis trial

    Nephrology Date published:

  • Establishing Core Cardiovascular Outcome Measures for Trials in Hemodialysis: Report of an International Consensus Workshop

    American Journal of Kidney Diseases Date published:

  • The effect of canagliflozin on amputation risk in the CANVAS program and the CREDENCE trial

    Diabetes, Obesity and Metabolism Date published:

  • Predictors of Change in Left-Ventricular Structure and Function in a Trial of Extended Hours Hemodialysis

    Journal of Cardiac Failure Date published:

  • 27-OR: Effect of Canagliflozin on Total Hospitalization for Heart Failure Events in Patients with Type 2 Diabetes and Chronic Kidney Disease

    Diabetes Date published:

  • 1130-P: Mediators of the Effects of Canagliflozin (CANA) on Heart Failure (HF) and CV Death in Patients with Type 2 Diabetes (T2D) and Chronic Kidney Disease (CKD)

    Diabetes Date published: